Area of research
Pharmacology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Warfarin, Genome-wide association study, Pharmacology, Dosing, and Pharmacogenetics.
Evaluating <scp>IL1RA</scp>‐Autoantibodies Across <scp>SARS</scp>‐<scp>CoV</scp>‐2‐Related Diseases
The Clinical Pharmacogenetics Implementation Consortium Guideline for <i>SLCO1B1</i>, <i>ABCG2</i>, and <i>CYP2C9</i> genotypes and Statin‐Associated Musculoskeletal Symptoms
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
Genetic Risk Factors in Drug‐Induced Liver Injury Due to Isoniazid‐Containing Antituberculosis Drug Regimens
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles
Shared Genetic Risk Factors Across Carbamazepine‐Induced Hypersensitivity Reactions
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
A common missense variant of LILRB5 is associated with statin intolerance and myalgia
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study
Time to onset of bisphosphonate‐related osteonecrosis of the jaws: a multicentre retrospective cohort study
Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population
Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
Genome-Wide Association Study of Warfarin Maintenance Dose in a Brazilian Sample
Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Phenotype Standardization for Statin-Induced Myotoxicity
Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System
Patients Benefit From Genetics-Guided Coumarin Anticoagulant Therapy
A Randomized Trial of Genotype-Guided Dosing of Warfarin
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study
A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy